News

The recall has been given a Class II classification, indicating there is a significant level of risk posed to consumers in ...
Mushrooms sold across two states have been recalled over fears they could be harboring listeria, a bug that "can cause ...
The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed ...
The U.S. Food and Drug Administration raised concerns over ink printing potentially running when exposed to high temperatures ...
The agency claims Whoop is marketing an unauthorized medical device intended to diagnose, cure, treat or prevent a disease.
The FDA has issued an early warning regarding Medline Fluid Delivery Sets, which may pose a significant health risk due to a potentially incorrect assembly, according to a Dec. 30 news release ...
"FDA issues new boxed warning for Prolia, a bone disease drug, due to increased risk of severe hypocalcemia in chronic kidney disease patients. Here's what healthcare professionals should know." ...
The US Food and Drug Administration (FDA) has added a boxed warning to the label of the osteoporosis drug denosumab (Prolia) about increased risk for severe hypocalcemia in patients with advanced ...
Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...
FDA asks Moderna and Pfizer-BioNTech to update warning labels on Covid-19 vaccines with expanded age range of men at risk for myocarditis. Skip to Main Content Manage alerts for this article ...
The Food and Drug Administration's boxed warnings on the labels of Rinvoq , Xeljanz and Lilly's Olumiant flags the risk of cardiovascular death and stroke in high-risk patients who are aged 50 ...